Yale Jen
Stock Analyst at Laidlaw & Co.
(0)
# 5081
Out of 5,240 analysts
18
Total ratings
11.11%
Success rate
-46.93%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Abivax | Initiates Coverage On: Buy | 48 | 6.24 | 669.23% | 1 | Jul 29, 2024 | |
MEI Pharma | Downgrades: Hold | n/a | n/a | n/a | 1 | Jul 23, 2024 | |
Affimed | Maintains: Buy | 15 25 | 1.1 | 2172.73% | 1 | Jun 13, 2024 | |
BiomX | Initiates Coverage On: Buy | 25 | 0.74 | 3278.38% | 1 | May 28, 2024 | |
IN8bio | Initiates Coverage On: Buy | 8 | 0.32 | 2243.75% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.72 | 481.4% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 240 | 2.04 | 11664.71% | 1 | Sep 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 0.16 | 18650% | 1 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Dec 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 720 | n/a | n/a | 1 | Sep 19, 2017 |